Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine

NCT05542693 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
COVID-19 Vaccine

Interventions

BIOLOGICAL: RNA MCTI CIMATEC HDT 5µg
BIOLOGICAL: RNA MCTI CIMATEC HDT 10µg
BIOLOGICAL: Covishield® - AstraZeneca
BIOLOGICAL: Comirnaty® - Pfizer

Sponsor

Azidus Brasil

Collaborators

[object Object]